Achieve Life Sciences Ownership | Who Owns Achieve Life Sciences?
Achieve Life Sciences Ownership Summary
100.00% retail investors. Franklin Biotechnology Discovery A is the top mutual fund, with 6.35% of its assets in Achieve Life Sciences shares.
ACHV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Achieve Life Sciences | - | - | 100.00% |
Sector | Healthcare Stocks | 46.80% | 8.14% | 45.06% |
Industry | Biotech Stocks | 44.70% | 7.99% | 47.31% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2023 | 1 | - | 100 | - | - | - | 1 | - | - | - |
Jun 30, 2020 | 11 | -26.67% | 7,172,659 | 134.85% | 20 | 21.10% | 5 | -54.55% | 1 | - |
Mar 31, 2020 | 15 | -6.25% | 3,054,176 | 29.92% | 9 | 17.10% | 11 | -8.33% | 1 | -75.00% |
Dec 31, 2019 | 16 | 14.29% | 2,350,821 | 85.18% | 7 | 45.13% | 12 | 100.00% | 4 | - |
Sep 30, 2019 | 14 | - | 1,269,468 | -15.79% | 4 | 17.28% | 6 | -25.00% | 4 | 33.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Franklin Biotechnology Discovery A | 2.18M | 6.35% | - |
Franklin Biotechnology Discv A(acc)USD | 1.69M | 4.92% | - |
Vanguard Total Stock Mkt Idx Inv | 1.03M | 2.99% | - |
iShares Russell 2000 ETF | 831.63K | 2.42% | -1.88K |
Vanguard Institutional Extnd Mkt Idx Tr | 629.87K | 1.83% | - |
Fidelity Small Cap Index | 347.96K | 1.01% | -6.68K |
Simplify Propel Opportunities ETF | 217.84K | 0.63% | - |
Fidelity Extended Market Index | 188.93K | 0.55% | -11.55K |
iShares Russell 2000 Growth ETF | 183.58K | 0.53% | - |
Vanguard Russell 2000 ETF | 157.13K | 0.46% | -986.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 04, 2024 | Stewart Richard Alistair | Executive Chairman | Buy | $49.06K |
Mar 04, 2024 | Stewart Richard Alistair | Executive Chairman | Buy | $45.85K |
Mar 04, 2024 | Bencich John | CEO | Buy | $45.85K |
Mar 04, 2024 | Bencich John | CEO | Buy | $49.06K |
May 30, 2023 | Bencich John | CEO | Buy | $27.50K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q1 | 4 | - |
2023 Q2 | 1 | - |
2023 Q1 | - | - |
2022 Q4 | 2 | - |
2022 Q3 | - | - |
ACHV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools